DELPHARM Development and CREAPHARM CLINICAL SUPPLIES have collaborated to fully meet HMNC Brain Health’s need and makes its task easier while handling end-to-end operations for both non-GMP technical batches and clinical batches.

HMNC Brain Health is a disruptive clinical stage biopharmaceutical company pioneering Precision Psychiatry, powered by its AI Platform, and focusing on Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD).

Case study PDF - 1.3 MiB